Cargando…
SAT510 I-131 Therapy with Dosimetry for Advanced Thyroid Carcinoma: Recombinant TSH vs Thyroid Hormone Withdrawal
Disclosure: D. Awad: None. J. Hamsa: None. A. Fingeret: None. C. Johnson: None. F. Rutar: None. C. Carson: None. A. Kotwal: None. A. Patel: None. A. Thornburg: None. W.S. Goldner: None. Background: Dosimetry can be used to calculate an optimal and safe dose of Iodine-131 (I-131) for treatment of adv...
Autores principales: | Awad, Dana, Hamsa, Jarod, Fingeret, Abbey, Johnson, Craig, Rutar, Frank, Carson, Carrie, Kotwal, Anupam, Patel, Anery, Thornburg, Angela, Goldner, Whitney Sears |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553618/ http://dx.doi.org/10.1210/jendso/bvad114.1982 |
Ejemplares similares
-
MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020) -
MON-506 Assessment of Quality of Life in Persons with Thyroid Cancer and Thyroid Nodules: A Single Center Experience
por: Raghunathan, Sapna, et al.
Publicado: (2020) -
Impaired Sleep Influences Health Care Related Quality of Life in Patients With Well Differentiated Thyroid Carcinoma
por: Disanti, Domenic, et al.
Publicado: (2021) -
SUN-510 Prolonged RAIA Induced Thyroiditis After 131 I Therapy for Graves’ Hyperthyroidism
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020) -
SAT-510 Association of Myotonic Dystrophy with Autoimmune Endocrinopathies and Thyroid Carcinoma
por: Proudan, Nikoletta, et al.
Publicado: (2020)